-
Elrombopag
Zita reAPI Indication Innovator Patent Expiry Date (The US) Elrombopag ITP & Aplastic anemia Novartis & GSK Chivabvu. 20, 2023 -
Elagolix 834153-87-6
Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP ElagolixCAS:834153-87-6 Endometriosis Mumba -
Ezetimibe
Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP Ezetimibe Hyperlipidemia Mumba/USP 24511 √ -
Enalapril Maleate
Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP Enalapril Maleate Hypertension USP/EP